go 6976 has been researched along with tris(2-pyridylmethyl)amine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hahn, TR; Hong, JW; Lee, MS; Lim, IK; Moon, E; Ryu, MS | 1 |
1 other study(ies) available for go 6976 and tris(2-pyridylmethyl)amine
Article | Year |
---|---|
TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Topics: Animals; Carbazoles; Caspase 3; Caspases; CDC2 Protein Kinase; Cell Cycle; Cell Death; Cyclin A; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; G2 Phase; Genes, Tumor Suppressor; Humans; Immediate-Early Proteins; Indoles; Maleimides; Mice; NIH 3T3 Cells; Nocodazole; Protein Binding; Protein Kinase C; Protein Kinase C-delta; Pyridines; Retinoblastoma Protein; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; U937 Cells | 2004 |